Pay in 4 interest-free payments of $5.40 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Early-phase clinical trial data, including results from a Phase 2 randomised controlled trial published in The New England Journal of Medicine in 2023 (Jastreboff et al., NEJM 2023), demonstrated significant weight reduction in adults with obesity (without type 2 diabetes), with participants receiving the highest dose losing a mean of approximately 24% of their body weight over 48 weeks
JAMA 305 , 25252531 (2011)
Int J Mol Sci, 2022, Vol 23(2), Article 786
This is because Ozempic may stimulate the growth of existing MTC or increase the risk of developing MTC
Jason Giffi, DO, DABOM board-certified in obesity medicine, a certified personal trainer, and an Ironman triathlete
US$ 29.16
US$ 21.82
US$ 25.54
US$ 22.76
US$ 27.59
